Brief: Medtronic And Merit Medical Systems Enter Into Agreement To Offer New, FDA-Cleared Viaverte System
24/03/2026 12:33
March 24 (Reuters) - Merit Medical Systems Inc MMSI.O: MEDTRONIC AND MERIT MEDICAL SYSTEMS ENTER INTO AGREEMENT TO OFFER NEW, FDA-CLEARED VIAVERTE™ SYSTEM, A BASIVERTEBRAL NERVE ABLATION TREATMENT FOR CHRONIC VERTEBROGENIC LOWER-BACK PAIN Source text: ID:nPn5cT3gba Further company coverage: MMSI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Merit Medical Systems
See all newsMerit Medical Systems Inc reports results for the quarter ended March 31 - Earnings Summary
Merit Medical Q2 adjusted EPS beats estimates, raises 2026 outlook
Brief: Merit Medical Systems Q2 Adjusted EPS USD 1.19 Vs. IBES Estimate USD 0.96
Brief: Merit Medical Shareholders Elect Scott R. Ward To Board Of Directors
Merit Medical Q1 adjusted EPS rises on therapeutic, foundational growth